Adamsbrown Wealth Consultants’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,916	Closed	-$228K	–	100
2024 Q3	$228K	Buy	1,916 +233	+14%	+$27.7K	0.08%	81
2024 Q2	$240K	Buy	+1,683	New	+$240K	0.09%	75